A US judge has denied Monsanto a new trial after finding the agrochemical company liable for its cancer-causing product. The victim’s lawyer hailed the decision as “a triumph for our legal system.”
A judge in San Francisco on Monday upheld a jury’s verdict that found Monsanto liable for a groundkeeper’s cancer. However, the judge slashed damages from $289 million (€252 million) to $78 million.
The trial was the first of its kind to find Monsanto liable for not warning of the potential carcinogenic properties of glyphosate found in its Roundup herbicide.
What happened:
Dewayne Johnson, who worked as a groundkeeper at a school near San Francisco, was diagnosed with non-Hodgkin lymphoma in 2012, two years after starting his job. He often sprayed hundreds of gallons of Roundup on school grounds each year.
Johnson filed a lawsuit against Monsanto two years after being unable to work due to the disease.
In August, a jury ruled that Monsanto “acted with malice and oppression” by failing to acknowledge glyphosate as a cancer-causing agent. At the time, the court ordered Monsanto to pay $289 million in damages.
Monsanto fought the verdict, arguing that the large sum for damages be rescinded and a new trial take place. But on Monday, judge Suzanne Bolanos upheld the jury’s verdict while significantly cutting the damages.
Read more: Glyphosate: The key points in an endless debate
Does glyphosate cause cancer?
While critics are quick to describe glyphosate — the main chemical substance in Roundup — as carcinogenic, research is far from definitive on the question. Here’s what international bodies, environmental authorities and researchers have to say:
The European Union’s European Food Safety Authority said in 2015: “EU peer review experts, with only one exception, concluded that glyphosate is unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard to its carcinogenic potential.”
Read more: Weed killer glyphosate EU license extended for further five years
The World Health Organization’s International Agency for Cancer Research in 2015 classified glyphosate as “probably carcinogenic to humans.” At the same time, it said that, “For the herbicide glyphosate, there was limited evidence of carcinogenicity in humans for non-Hodgkin lymphoma. The evidence in humans is from studies of exposures, mostly agricultural, in the USA, Canada and Sweden published since 2001.”
The US Environmental Protection Agency in 1985 labeled glyphosate a “possible human carcinogen,” but that classification was rescinded in 1991 by an internal committee, saying there wasn’t enough evidence to claim that it was carcinogenic. It was consequently labeled a chemical with “evidence of non-carcinogenicity for humans.” A new review process launched in 2015 said data “at this time do no (sic) support a carcinogenic process for glyphosate.”
Monsanto’s take
Monsanto has argued that its product does not a pose a threat to humans. In a 2016 report on glyphosate, the agrochemical company said the agent “exhibits low toxicity to humans and non-plant wildlife over both short- and long-term exposures.”
Read more: Did Monsanto know its weed killer could be deadly to people?
What happens next?
Johnson has until December 7 to accept the reduced amount in damages. If he does not wish to accept the amount, he can demand a new trial.
DW editors send out a selection of the day’s hard news and quality feature journalism. You can sign up to receive it directly here.
ls/aw (AFP, AP)
